DNM1L and Huntington disease: In particular, treatment with CHIR99021 stabilizes calpastatin (CAST), thereby inhibiting calpain activation and preventing Drp1-mediated mitochondrial fragmentation, reducing HD-associated neuropathology and behavioral defects [157,220].